drugset / Trial / NCT07645924
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with placebo, in the acute treatment of migraine.
Timeline
- Start
- 2026-07
- Primary completion
- 2027-02
- Completion
- 2027-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elismetrep | Small molecule | 10 mg | Oral |
| Subject | Elismetrep | Small molecule | 20 mg | Oral |